Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 259

Posts Tagged ‘neurostimulation’

The “Europe Neurostimulation Market – Growth, Trends, and Forecast (2019 – 2024)”

Posted by fidest press agency su martedì, 20 agosto 2019

The major factors for the growth of the Europe neurostimulation market include the increase in geriatric population and rising prevalence of neurological disorders, rising demand for minimally invasive surgeries, and technological advancement.Among the age-related neurodegenerative disorders, Parkinson’s disease (PD) is the second most common, after Alzheimer’s disease. An estimated 10 million people are affected by this disease, globally. According to NHS UK, Parkinson’s disease is found affecting around 1 in 500 people, which means there are an estimated 127,000 people in the UK with the condition.Most people with Parkinson’s start to develop symptoms when they’re over 50, although around 1 in 20 people with the condition first experience symptoms when they’re under 40. Furthermore, neurostimulation devices also play a significant role in pain management.Recently in November 2018, Abbott announced the launch of the new DRG Invisible Trial System, which is approved by the United States Food and Drug Administration (FDA) and received CE Mark in Europe.Thus, owing to the rising prevalence of neurological diseases and increasing technological advancements the market is expected to witness high growth over the forecast period.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »